Air pollution causes up to 36,000 deaths in the UK every year and both cause and worsen lung disease.
In this article we discuss how to incorporate environmental considerations when selecting inhaler devices for patients newly diagnosed with respiratory disease.
As of April 2021, regional health and care needs in England will be coordinated through Integrated Care Systems (ICSs) (https://www.england.nhs.uk/integratedcare/what-is-integrated-care/).
In this webinar inspiring speakers, Dr Andrew Appleton, Clinical Digital Lead & Chief Clinical Information Officer, Bristol, North Somerset and South Gloucestershire CCG and Dr Shanti Vijayaraghavan, Consultant Physician, Diabetes & Endocrinology, Barts Health NHS Trust, Newham Unive
An estimated 1.2 million people are living with COPD in the UK1 and research suggests that this number is growing (BLF 2020).
PCRS support initiatives to improve air quality and minimise short- and long-term damage to the environment, particularly those with an impact on climate change resulting from greenhouse gases.